According to ImmunoPrecise Antibodies's latest financial reports the company's current earnings (TTM) are -S$28.19 M. In 2023 the company made an earning of -S$15.11 M an increase over its 2022 earnings that were of -S$25.91 M.The earnings displayed on this page is the company's Pretax Income.